trial

Cognitive Behavioral Therapy Added to Risperidone for Schizophrenia

NCTId NCT07609953
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 42 (actual)
Sponsored by Hasanuddin University
Primary completion 2026-01-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
42 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2025-11-01
Primary completion
2026-01-31
Eligibility
ALL · 20 Years · 50 Years

Interventions & indications

Drugs
RisperidoneCognitive Behavioral Therapy

Sponsors

Hasanuddin UniversityLead Sponsor

Investigators

1
Maya Angela Lisal, Medical DoctorPrincipal Investigator

Sites

1 total
Makassar, Indonesia

Facts & assertions

4 sourced
Enrollment
42
Phase
NA
Primary Completion Date
2026-01-31
Status
COMPLETED
relationships
The graph out of here
drug
Risperidone
drug
Cognitive Behavioral Therapy
drug
lead_sponsor
Hasanuddin University
company
indication
Schizophrenia
indication
Schizophrenia
indication
Psychotic Disorders
indication
investigator
Maya Angela Lisal, Medical Doctor
person